These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31528224)

  • 1. Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer.
    Wang M; Hu H; Wang Y; Huang Q; Huang R; Chen Y; Ma T; Qiao T; Zhang Q; Wu H; Chen Q; Han D; Wang G; Wang X
    J Cancer; 2019; 10(19):4603-4613. PubMed ID: 31528224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
    Li C; Gao Y; Li Y; Ding D
    Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy.
    Wang M; Han D; Yuan Z; Hu H; Zhao Z; Yang R; Jin Y; Zou C; Chen Y; Wang G; Gao X; Wang X
    Cell Death Dis; 2018 Nov; 9(12):1149. PubMed ID: 30451820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
    Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
    Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis.
    Xian Z; Hu B; Wang T; Zeng J; Cai J; Zou Q; Zhu P
    Onco Targets Ther; 2020; 13():7571-7583. PubMed ID: 32801774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis.
    Zhu J; Shi H; Liu H; Wang X; Li F
    Oncotarget; 2017 Sep; 8(39):65253-65264. PubMed ID: 29029428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TUG1 Regulates Proliferation of Cardiac Fibroblast
    Guo Y; Sun Z; Chen M; Lun J
    Front Cardiovasc Med; 2021; 8():646806. PubMed ID: 34540908
    [No Abstract]   [Full Text] [Related]  

  • 15. In-Silico and In-Vitro Investigation of Key Long Non-coding RNAs Involved in 5-Fluorouracil Resistance in Colorectal Cancer Cells: Analyses Highlighting NEAT1 and MALAT1 as Contributors.
    Sahebnasagh R; Azizi Z; Komeili-Movahhed T; Zendehdel K; Ghahremani MH
    Cureus; 2024 Aug; 16(8):e66393. PubMed ID: 39246994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
    Zou X; Wang J; Tang L; Wen Q
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):482-490. PubMed ID: 31183682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
    Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
    J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered multitargeting exosomes carrying miR-323a-3p for CRC therapy.
    Pang Y; Chen X; Xu B; Zhang Y; Liang S; Hu J; Liu R; Luo X; Wang Y
    Int J Biol Macromol; 2023 Aug; 247():125794. PubMed ID: 37442504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TUG1 promotes osteosarcoma cell proliferation and invasion through inhibition of microRNA-212-3p expression.
    Li H; Tian G; Tian F; Shao L
    Exp Ther Med; 2018 Aug; 16(2):779-787. PubMed ID: 30116332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.